Concepedia
4
Publications
1.5K
Citations
H-Index
2012
Active since
Affiliations
Manchester Academic Health Science Centre(Current)
AstraZeneca (United Kingdom)
University of Manchester
Sumitomo Dainippon Pharma (Japan)
Cancer Research UK Manchester Institute
Amy L. Adlard is an author at Manchester Academic Health Science Centre.
Publications per year
2012–2016
Acquired Resistance to Fractionated Radiotherapy Can Be Overcome by Concurrent PD-L1 Blockade
Simon J. Dovedi, Amy L. Adlard, Grazyna Lipowska‐Bhalla et al. · Cancer Research · 2014 · 1.3K citations · Full text
Systemic delivery of a TLR7 agonist in combination with radiation primes durable antitumor immune responses in mouse models of lymphoma
Simon J. Dovedi, Monique Melis, Robert W. Wilkinson et al. · Blood · 2012 · 144 citations
A novel systemically administered toll‐like receptor 7 agonist potentiates the effect of ionizing radiation in murine solid tumor models
Amy L. Adlard, Simon J. Dovedi, Brian A. Telfer et al. · International Journal of Cancer · 2014 · 50 citations · Full text
Intravenous administration of the selective toll-like receptor 7 agonist DSR-29133 leads to anti-tumor efficacy in murine solid tumor models which can be potentiated by combination with fractionated radiotherapy
Simon J. Dovedi, Amy L. Adlard, Yosuke Ota et al. · Oncotarget · 2016 · 30 citations · Full text
Rows per page
1–4 of 4